Effect of Arjun Chal on cardiovascular risk factors - a randomized controlled clinical trial.
J Complement Integr Med
; 19(1): 145-154, 2021 May 10.
Article
in English
| MEDLINE | ID: covidwho-1775488
ABSTRACT
OBJECTIVES:
Cardiovascular diseases have a multifaceted, it causes modern epidemic; Recognizing in the risk factor stage, is crucial, given the risk of progression to cardiovascular disease. Ibn Sina, described CVDs as a resultant of gradual derangement of Quwwat ghadhiya (Nutritive faculty); in which management with ghidha' (diet), tadabir (regimens), dawa' (drug) has been received. To evaluate the effect of Arjun Chal (Terminalia arjuna) in CVD risk factors. And to evaluate the drug safety.METHODS:
This is a randomized controlled clinical trial. Total 120 patients were screened at OPD of NIUM hospital, Bangalore during 2018-19, only 48 patients fulfilled the inclusion criteria and signed written informed consent and their detailed medical history was recorded. Arjun Chal powder (5 gm BD) for eight weeks administered in test group (n=24), Amlodipine (5 mg) and Atorvastatin (10 mg) once a day for same duration administered in control group (n=24). Efficacy of the drug assessed by the Lipid profile, BP and BMI; lipid profile were performed at baseline and at 8 weeks, while BP and BMI performed at baseline, 15, 30, 45, and 60th day intervals. Study was completed by 40 patients. The results of both the therapies were then compared and statistically analyzed.RESULTS:
Totally, both groups reduces assessment parameters i.e. statistically highly significant (p<0.001). Test group showed greater reduction in terms of all assessment parmeters. But, the difference between both the groups was statistically non-significant p>0.05.CONCLUSIONS:
Both test and control drugs were effective, but Arjun Chal had a slight edge over amlodipne and atorvastatin, and was found to be safe and well tolerated. It has a cardio protective potential and hence effective to delay/prevent CVD in patient with cardiovascular risk factor.Keywords Unani System of Medicine; T. arjuna; Arjun Chal; Efficacy; Safety; Cardiovascular risk factor.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Topics:
Traditional medicine
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
J Complement Integr Med
Year:
2021
Document Type:
Article
Affiliation country:
Jcim-2020-0439
Similar
MEDLINE
...
LILACS
LIS